A large number of parameters will influence and mediate the activity and the pharmacological response of dental fluoride products after systemic or topical treatment. This report reviews some aspects of the pharmacokinetics of fluoride in man, fluoride bio-availability, plasma kinetics, and kinetics of fluoride in saliva and plaque fluid. Pharmacokinetic studies in growing dogs show that 90% of a single injected fluoride dose is retained shortly after birth, but at maturity it decreases to about 50%. The degree of fluoride accumulating in cal-cifying tissues seems to be strongly related to age. The bio-availability of fluoride from swallowed fluoride toothpaste is shown to be decreased if the toothpaste is ingested close to a meal. Several studies show that fluoride exerts its cariostatic effects through the liquid phase surrounding the enamel. The importance of fluoride in the fluid environment of the teeth and the kinetics of fluoride in saliva are discussed. Clinical studies using different slow-release fluoride systems indicate that they are promising cariostatic agents—in particular in-tra-dural slow-release devices and lozenges. A new micro-analytical method to study the kinetics of fluoride in plaque fluid collected from single tooth sites has been developed. Preliminary studies show that the clearance of fluoride from plaque fluid is slowest in the upper incisor region, followed by the molar region, and faster in the lower incisor region. A site-by-site study of the concentration of fluoride in plaque fluid after topical fluoride administration could be extremely beneficial in optimization of the methods and recommended safety regimens for fluoride therapy.
Get full access to this article
View all access options for this article.
References
1.
COLLINSL.M.C., and DAWESC. (1987): The Surface Area of the Adult Human Mouth and Thickness of the Salivary Film Covering the Teeth and Oral Mucosa, J Dent Res66: 1300–1302.
2.
CORPRONR.E.; CLARKJ.W.; ARNOLDJ.; MOREF.G.; MERRILLD.; and KOWALSKIC.J. (1987): Intraoral Effects on Acid-softened Enamel of NaF Lozenges Administered in Divided Daily Doses, J Dent Res66: 1020–1024.
3.
CORPRONR.E.; CLARKJ.W.; TSAIA.; MOREF.G.; MERRILLD.F.; KOWALSKIC.J.; TICET.R.; and ROWEC.E. (1986): Intraoral Effects of a Fluoride-releasing Device on Acid-softened Enamel, J Am Dent Assoc113: 383–388.
EKSTRANDJ.; ALVANG.; BOréUSL.; and NORLINA. (1977): Pharmacokinetics of Fluoride in Man After Single and Multiple Oral Doses, Eur J Clin Pharmacol12: 311–317.
6.
EKSTRANDJ., and EHRNEBOM. (1979): Influence of Milk Products on Fluoride Bioavailability in Man, Eur J Clin Pharmacol16: 211–215.
7.
EKSTRANDJ., and EHRNEBOM. (1980): Absorption of Fluoride from Fluoride Dentifrices, Caries Res14: 96–102.
8.
EKSTRANDJ.; EHRNEBOM.; and BOréUSL.O. (1978): Fluoride Bioavailability After Intravenous and Oral Administration: Importance of Renal Clearance and Urine Flow, Clin Pharm Ther23: 329–337.
9.
EKSTRANDJ.; LAGERLÖFF.; and OLIVEBYA. (1986): Some Aspects of the Kinetics of Fluoride in Saliva. In: Factors Relating to De/Remineralisation of Teeth, LeachS.A., and EdgarW.M., Eds., Oxford: IRL Press, pp. 91–98.
10.
EKSTRANDJ., and SPAKC.-J. (1989): Fluoride Pharmacokinetics—Its Implications in the Fluoride Treatment of Osteoporosis, J Bone and Mineral Res (in press).
11.
EKSTRANDJ.; SPAKC.-J.; and OLIVEBYA. (1989): Studies on the Pharmacokinetics of a New Fluoride Lozenge, Caries Res23:99, Abst. No. 30.
12.
EKSTRANDJ., and WHITFORDG. (1984): Fluoride Metabolism: Longitudinal Study in Growing Dogs, J Dent Res63:206, Abst. No. 324.
13.
EKSTRANDJ., and WHITFORDG. (1988): Fluoride Metabolism. In: Fluoride In Dentistry, EkstrandJ., FejerskovO., and SilverstoneL.M., Eds., Copenhagen: Munksgaard, pp. 150–170.
14.
ELLINGSENJ.E., and EKSTRANDJ. (1985): Plasma Fluoride Levels in Man Following Intake of SnF2 in Solution or Toothpaste, J Dent Res64: 1250–1252.
15.
FEATHERSTONEJ., and TEN CATEJ.M. (1988): Physiochemical Aspects of Fluoride-Enamel Interactions. In: Fluoride in Dentistry—An International Textbook, EkstrandJ., FejerskovO., and SilverstoneL.M., Eds., Copenhagen: Munksgaard, Chapter 6, pp. 125–149.
FRIEDMANM. (1981): Fluoride Uptake by Powdered Human Enamel Treated with Prolonged Acting Fluoride Pellets in vitro, Arch Oral Biol26:131–134.
18.
HENSCHLERD.; BÜTTNERW.; and PATZJ. (1975): Absorption, Distribution in Body Fluids, and Bioavailability of Fluoride. In: Calcium Metabolism, Bone and Metabolic Bone Diseases, KuhlercordtF., and KruseH. P., Eds., Berlin: Springer Verlag, pp. 111–121.
19.
KEKKIM.; LAMPAINENE.; KAURANENP.; HOIKKAV.; ALHAVAE.M.; and PASTERNACKA. (1982): The Nonlinear Tissue-Binding Character of Fluoride Kinetics in Normal and Ancphric Subjects, Nephron31: 129–134.
20.
KULAK.; KULAT.; DAVIDSONW.; and PARKERE. (1987): Pharmacological Evaluation of an Intraoral Fluoride-releasing Device in Adolescents, J Dent Res66: 1538–1542.
21.
LAGERLÖFF.; EKSTRANDJ.; and RØLLAG. (1988): Effect of Fluoride Addition on Ionized Calcium in Salivary Sediment and Saliva, Scand J Dent Res96: 399–404.
22.
LAGERLÖFF.; OLIVEBYA.; and EKSTRANDJ. (1987): Physiological Factors Influencing Salivary Clearance of Sugar and Fluoride, J Dent Res66: 430–435.
23.
LAMBROUD.; LARSENM.J.; FEJERSKOVO.; and TACHOSB. (1981): The Effect of Fluoride in Saliva on Remineralization of Dental Enamel in Humans, Caries Res15: 341–345.
24.
LARSENJ.J. (1973): Dissolution of Enamel, Scand J Dent Res81: 518–522.
25.
LARSENM.J., and BRUUNC. (1986): Enamel/Saliva—Inorganic Chemical Reactions. In: Textbook of Cariology, ThylstrupA., and FejerskovO., Eds., Copenhagen: Munksgaard, pp. 181–203.
26.
LARSONR.H., and MELLBERGJ.R. (1977): Experiments on Local and Systemic Action of Fluoride in Caries Inhibition in the Rat, Arch Oral Biol22: 437–439.
27.
McKNIGHT-HANESC., and HANESP. (1986): Effective Delivery Systems for Prolonged Fluoride Release: Review of Literature, J Am Dent Assoc113: 431–436.
28.
MEIERP.M.; DILLONJ.; and MARCOD.D. (1978): Enhancement of Caries Prevention Effects of Fluoride Tablets via Sustained Release, JADR Prog & Abst57: No. 548.
29.
MIRTHD.B.; ADDERLEYD.D.; AMSBAUGHS.M.; MONELI.-TORRENSE.; LiS.H.; and BOWENW.U. (1983): Inhibition of Experimental Dental Caries Using an Intraoral Fluoride-releasing Device, J Am Dent Assoc107: 55–59.
30.
MIRTHD.B.; SHERNR.J.; EMILSONC.G.; ADDERLYD.D.; LI, S-1I.; GOMEZI.M.; and BOWENW.U. (1982): Clinical Evaluation of an Intraoral Device for the Controlled Release of Fluoride, J Am Dent Assoc105: 791–797.
31.
OPHAUGR.H.; JENKINSS.U.; SINGERL.; and KREBSBACHL. (1987): Acid Diffusion Analysis of Different Forms of Fluoride in Human Dental Plaque, Arch Oral Biol32: 459–461.
32.
RICHARDSA.; KRAGSTRUPJ.; and NIELSEN-KUDSKF. (1985): Pharmacokinetics of Chronic Fluoride Ingestion in Growing Pigs, J Dent Res64: 425–430.
33.
RØLLAG., and ØGAARDB. (1986): Studies on the Solubility of CaF2, in Human Saliva. In: Factors Relative to Demineralisation and Remineralisation of the Teeth, LeachS.A., Ed., Oxford: IRL Press, pp. 45–50.
34.
SPAKC.-J., and EKSTRANDJ. (1988): Effect of Food Intake on the Bio-availability of Ingested Fluoride Toothpaste, J Dent Res67:357, Abst. No. 1953.
35.
SPAKC.-J.; SJÖSTEDTS.; ELEBORGL.; VERESSB.; PERBECKL.; and EKSTRANDJ. (1989): The Tissue Response of Human Gastric Mucosa after Fluoride Ingestion, Br Med J298: 1686–1687.
36.
SPAKC.-J.; SJÖSTEDTS.; ELEBORGL.; VERESSB.,; PERBECKL.; and EKSTRANDJ. (1990): The Tissue Reaction of Gastric Mucosa after Fluoride Gel Ingestion, J Dent Res69 (Spec Iss):827–828.
37.
STOOKEYG.E., and MUHLERJ.C. (1976): Laboratory Studies Concerning Fluoride Metabolism Using Two Different Types of Fluoride Tablets, J Dent Child33: 90–100.
38.
TATEVOSSIANA. (1978): Distribution and Kinetics of Fluoride Ions in the Free Aqueous and Residual Phases of Human Dental Plaque, Arch Oral Biol23: 893–898.
39.
TATEVOSSIANA., and GOULDC. (1976): The Composition of the Aqueous Phase in Human Dental Plaque, Arch Oral Biol21: 319–323.
40.
TEN CATEJ.M., and DUIJSTERSP.P.E. (1983): Influence of Fluoride in Solutions on Tooth Demineralization. I. Chemical Data, Caries Res17: 193–199.
41.
WEATHERELLJ.A.; STRONGM.; RALPHJ.P.; and ROBINSONC. (1988): Availability of Fluoride at Different Sites in the Buccal Sulcus, Caries Res22: 129–133.
42.
WEATHERELLJ.A.; STRONGM.; ROBINSONC.; and RALPHJ.P. (1986): Fluoride Distribution in the Mouth after Fluoride Rinsing, Caries Res20: 111–119.
WHITFORDG.M.; ALLMANND.W.; and SHAHEDA.R. (1987): Topical Fluorides: Effects on Physiologic and Biochemical Processes, J Dent Res66: 1072–1078.
45.
WHITFORDC.M., and EKSTRANDJ. (1988): Fluoride Toxicity. In: Fluoride in Dentistry, EkstrandJ., FejerskovO., and SilverstoneL.M., Eds., Copenhagen: Munksgaard, pp. 171–189.
46.
WHITFORDG.M., and SCHUSTERG.S. (1982): Systemic versus Watcrborne Fluoride and Dental Caries, IADR Prog & Abst61: No. 324.
47.
WILLIAMSD.; MEIERP.M.; GRONP.; HITCHCOCKC.J.; MULLENST.J.; and BOWENW.H. (1982): Cariostatic Microcapsules for Aerosol Delivery, J Pedodont6: 218–228.
